ENvue Medical Announces 1-for-12 Reverse Stock Split

What Happened

• ENvue Medical, Inc. (NASDAQ: FEED) filed an 8-K reporting a 1-for-12 reverse stock split that takes effect at 12:01 a.m. Eastern on September 1, 2026. The split was approved at a special stockholder meeting on August 14, 2026 and implemented via a Certificate of Amendment filed with Delaware on August 28, 2026. The company will continue to trade under the symbol FEED on Nasdaq but will have a new CUSIP (63008J876). A press release dated August 28, 2026 announcing the split was filed as Exhibit 99.1.

Key Details

• Reverse split ratio: 12-for-1, effective September 1, 2026 at 12:01 a.m. ET.
• Outstanding shares: 11,084,616 pre-split (as of Aug 28, 2026) → approximately 923,718 post-split (subject to rounding).
• Fractional shares: no fractional shares will be issued; fractional interests will be rounded up to the nearest whole share.
• Equity adjustments: outstanding options, warrants, restricted stock/units and convertible securities will be adjusted (share amounts divided by 12; exercise/conversion prices multiplied by 12).
• Authorization/par value: number of authorized common shares (40,000,000) and par value unchanged.

Why It Matters

• The reverse split consolidates the company’s outstanding shares into fewer, higher-priced shares while leaving each holder’s proportional ownership and voting power essentially unchanged (minor changes possible from rounding).
• Important practical effects for investors: traded share count and per-share figures (price, EPS denominators, option strike/share counts) will be adjusted; the stock will continue trading on Nasdaq under FEED but with a new CUSIP.
• Investors holding options, warrants, RSUs or other convertible instruments should expect contract terms to be adjusted as described in the filing.